Clinical Trials

Advanced Solid Tumour

NCT07390383 2026-05-13

A Phase II Clinical Trial of LBL-024 Combination Drug in Patients With Advanced Solid Tumour[Substudy 04]

Phase 2 Recruiting

110 enrolled

Advanced Solid Tumour

NCT06761417 2026-05-07

A Prospective, Single-arm Clinical Study of Liposomal Mitoxantrone Combination Regimen in the Treatment of Relapsed and Refractory Solid Tumors in Children, Adolescents and Young Adults

Phase 2 Recruiting

49 enrolled

GastrointestinalOther solid neoplasm

Solid Tumors

NCT07412613 2026-04-22

Neoadjuvant/Adjuvant AK104 in Microsatellite Instability-high or Mismatch Repair-deficient, Resectable Colon Cancer

Phase 3 Recruiting

386 enrolled

Resectable Colon Cancer

NCT06741644 2026-04-15

A Phase I/II Study of CS2009 in Participants With Advanced Solid Tumors

660 enrolled

Phase 1/2 Active not recruiting

Advanced Solid Tumors

NCT03585465 2026-03-18

Metro-PD1

63 enrolled

Childhood Solid Tumor

NCT07477743 2026-03-17

A Phase Ib Clinical Study on the Safety and Efficacy of HC010 Combinations in Advanced Solid Tumors

Phase 1 Recruiting

331 enrolled

Advanced Solid Tumor Cancer

NCT06703177 2025-12-03

A Study of SHR-1826 for Injection in Combination With Other Antitumor Therapies in Subjects With Solid Tumors

876 enrolled

Advanced Solid Tumors

NCT04047862 2025-08-22

Study of Ociperlimab (BGB-A1217) in Combination With Tislelizumab in Advanced Solid Tumors

446 enrolled 49 charts

Locally Advanced and Metastatic Solid Tumors

NCT06208410 2025-07-25

A Clinical Study of JS105 in Combination With Other Anti-tumor Therapies in Patients With Solid Tumors

306 enrolled

Advanced Solid Tumors

NCT05625412 2025-06-13

A Study of BMS-986360/CC-90001 Alone and in Combination With Chemotherapy or Nivolumab in Advanced Solid Tumors

70 enrolled

Advanced Solid Tumors

NCT06139211 2024-12-20

A Phase Ib/II Study Of JS015 Combination Therapy in Advanced Solid Tumors

186 enrolled

Advanced Solid Tumor

NCT00483366 2024-09-23

Imatinib Mesylate, Gemcitabine, and Capecitabine in Treating Patients With Advanced Solid Tumors

13 enrolled

Phase 2 Not yet recruiting

Unspecified Adult Solid Tumor, Protocol Specific

NCT06446388 2024-06-06

Study of QLS31905 and/or QL1706 Combination With Chemotherapy in the Advanced Malignant Solid Tumors

360 enrolled

GastrointestinalOther solid neoplasm

Advanced Solid Tumor

NCT04301557 2024-04-23

PD1 Antibody Toripalimab and Chemoradiotherapy for dMMR/MSI-H Locally Advanced Colorectal Cancer

Phase 2 Unknown

25 enrolled

DMMR Colorectal Cancer

NCT05700084 2024-04-19

Tolerability and Bioavailability of Utidelone Capsule in Patients With Advanced Solid Tumors

84 enrolled

Advanced Solid Tumor

NCT06041035 2023-09-18

A Study of QLS31905 Combination Chemotherapy as First-Line Treatment in Patients With Advanced Solid Tumors

Phase 1/2 Unknown

115 enrolled

Solid Tumor

NCT00084734 2023-08-04

Docetaxel, Capecitabine, and Cisplatin in Treating Patients With Advanced Solid Tumors

61 enrolled

Phase 2 Not yet recruiting

Unspecified Adult Solid Tumor, Protocol Specific

NCT05841134 2023-05-09

Tislelizumab Combined With Chemotherapy (CAPOX) in the Perioperative Treatment of MSI-H/dMMR Stage II or III Colorectal Cancer

25 enrolled

GastrointestinalOther solid neoplasm

MSI-H Colorectal Cancer

NCT05344742 2022-04-25

A Study of Mitoxantrone Hydrochloride Liposome Injection Combination Therapy in Chinese Patients With Advanced Solid Tumors

116 enrolled

Advanced Solid Tumor

NCT04802980 2021-07-28

A Study of HB002.1T Plus Chemotherapy in Subjects With Solid Tumor

72 enrolled

Solid Tumor

NCT02715531 2021-07-09

A Study of the Safety and Efficacy of Atezolizumab Administered in Combination With Bevacizumab and/or Other Treatments in Participants With Solid Tumors

243 enrolled

Solid Tumor

NCT02435927 2021-04-28

ASLAN001 in Combination With Oxaliplatin and Capecitabine or Oxaliplatin and 5-FU With Leucovorin

60 enrolled

Solid Tumors

NCT01369433 2020-09-01

A Rollover Protocol to Allow Continued Access to Tivozanib (AV 951) for Subjects Enrolled in Other Tivozanib Protocols

Phase NA Terminated

225 enrolled 7 charts

Solid Tumors

NCT00052273 2020-08-03

LY317615 Plus Capecitabine in Treating Patients With Advanced Solid Tumors

16 enrolled

Adult

NCT01128842 2018-12-19

A Study Of Neratinib (HKI-272) And Capecitabine In Japanese With Solid Tumor

7 enrolled 13 charts

Advanced Malignant Solid Tumors

NCT00215501 2018-11-02

Capecitabine or 5-Fluorouracil in Combination With Irinotecan and Cisplatin in Patients With Solid Tumor Malignancies

54 enrolled

Solid Tumor

NCT02648425 2018-10-25

Safety and Tolerability of ASLAN001 in Combination With Cisplatin and 5-FU or Cisplatin and Capecitabine

31 enrolled

Solid Tumor

NCT01705106 2018-05-30

Capecitabine and Celecoxib in Patients With Solid Cancers That Have Been Previously Treated With Standard Therapies

Phase 1 Terminated

21 enrolled 5 charts

Other solid neoplasmThoracic

Unspecified Adult Solid Tumor, Protocol Specific

NCT00004183 2016-07-14

Capecitabine in Treating Patients With Malignant Mesothelioma

Phase 2 Completed

27 enrolled

Mesothelioma, Malignant, Solitary Fibrous Tumor, Pleural

NCT02494596 2015-11-10

A Phase Ib, Open-label, Multicenter Study of the Safety and PK of the Combination of rhuMAb2c4 (Omnitarg), a Recombinant Humanized Antibody to HER2, and Capecitabine (Xeloda) in Patients With Advanced Solid Tumors

19 enrolled 16 charts

Solid Tumor

NCT00547547 2015-11-06

High-Selenium Brassica Juncea, Irinotecan, and Capecitabine in Treating Patients With Advanced Cancer

22 enrolled

Unspecified Adult Solid Tumor, Protocol Specific

NCT00121277 2015-07-23

Vorinostat and Capecitabine in Treating Patients With Metastatic or Unresectable Solid Tumors

28 enrolled

Unspecified Adult Solid Tumor, Protocol Specific

NCT00005839 2015-06-08

Oxaliplatin Plus Capecitabine in Treating Patients With Metastatic or Recurrent Solid Tumor

Unspecified Adult Solid Tumor, Protocol Specific

NCT01463982 2015-04-23

Phase I of OratecanTM in Combination With Capecitabine in Patients With Advanced Solid Malignancies

21 enrolled 10 charts

Solid Tumor

NCT01050985 2014-02-13

A Study of Temsirolimus Plus Capecitabine in Patients With Advanced Cancer

47 enrolled

Advanced Solid Tumors

NCT00043121 2013-12-11

Combination Chemotherapy in Treating Patients With Advanced Cancer That is Metastatic or Cannot Be Removed By Surgery

50 enrolled

Unspecified Adult Solid Tumor, Protocol Specific

NCT00074321 2013-06-06

Irinotecan, Oxaliplatin, and Capecitabine in Treating Patients With Unresectable Solid Tumors

84 enrolled

Unspecified Adult Solid Tumor, Protocol Specific

NCT00253565 2013-04-08

Imatinib Mesylate and Capecitabine in Treating Patients With Advanced Solid Tumors

25 enrolled

Unspecified Adult Solid Tumor, Protocol Specific

NCT00039390 2013-01-25

Gefitinib and Capecitabine in Treating Patients With Advanced Solid Tumors

41 enrolled

Unspecified Adult Solid Tumor, Protocol Specific

NCT00697502 2012-11-01

Study of Capecitabine In Patients With Solid Tumors

23 enrolled

Solid Tumors

NCT01315431 2012-07-24

A Study of Tesetaxel Plus Capecitabine in Patients With Solid Tumors

9 enrolled

Solid Tumor

NCT00077077 2012-05-16

DJ-927 and Capecitabine in Treating Patients With Locally Advanced or Metastatic Solid Tumors

Unspecified Adult Solid Tumor, Protocol Specific

NCT00006465 2010-06-11

Combination Chemotherapy in Treating Patients With Advanced Solid Tumors

22 enrolled

Unspecified Adult Solid Tumor, Protocol Specific

NCT00119171 2008-10-16

Ispinesib In Combination With Capecitabine In Patients With Solid Tumors

30 enrolled

Solid Tumor Cancer

NCT00192777 2007-10-08

Concurrent Xeloda and Radiotherapy for Bone Metastases

Phase 2 Unknown

20 enrolled